Clinical research progress of the hilar cholangiocarcinoma
ZHANG Yucheng
CHE Siyao
Abstract：Hilar cholangiocarcinoma(HCCA)is a common malignant tumor in the biliary system,accounting for about 56％-67％of cholangiocarcinomas.Due to the insidious onset and nonspecific early symptoms of HCCA,it is mostly found in the middle or late stage.In addition,its complex anatomical structure,infiltrative growth,and close connection with the surrounding blood vessels increase the difficulty of preoperative evaluation and subsequent treatment,resulting in a low overall survival rate and poor prognosis.Therefore,hepatoportal cholangiocarcinoma has become the focus of research and treatment in the field of hepatobiliary surgery.In recent years,with the continuous development of clinical diagnosis and treatment technology,such as using various imaging methods to make a clear diagnosis before operation,reducing jaundice of biliary drainage before operation,and reasonable selection of operation methods,the long-term survival of HCCA patients has been effectively improved.This article reviews the latest expert consensus and related research progress on hilar cholangiocarcinoma both domesticcally and internationally,providing a overview of preoperative evaluation,surgical techniques,and adjuvant therapy.
Keywords：Hepatohilar cholangiocarcinomaImaging examinationTypingSurgical approachAdjuvant therapy
Publication Date：2024-10-20
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：7( 514-520 )